You are here
Other Cohort Studies
RV230 was MHRP's initial effort to assess potential field sites for HIV vaccine studies in Nigeria, and in 2015 this study was in data analysis. They began d in 2009 and enrolled 550 participants. The study is assessing HIV-1, HIV-2, and hepatitis B and C prevalence along with the molecular diversity of HIV-1 within these populations
In 2013, MHRP initiated a cohort study (RV363) to determine incidence in men and women aged 18-35 in Maputo in collaboration with National Institute of Health (CISPOC).
This study, in Kombewa Kenya is titled: “Cohort and Development to Assess Incidence of HIV Infection, Retention Rate and Willingness of adults to participate in future HIV Vaccine trials in Western Kenya.” The study began in 2014.